نتایج جستجو برای: agvhd
تعداد نتایج: 407 فیلتر نتایج به سال:
Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because diagnosis of aGVHD is exclusively based on clinical symptoms and pathological findings, reliable and noninvasive laboratory tests for accurate diagnosis are required. An activating immunoreceptor, DNAM-1 (CD226), is expressed on T cells and natural killer ce...
MicroRNAs (miRNA) have emerged as central regulators of diverse biological processes and contribute to driving pathology in several diseases. Acute graft-versus-host disease (aGvHD) represents a major complication after allogeneic hematopoietic stem cell transplantation, caused by alloreactive donor T cells attacking host tissues leading to inflammation and tissue destruction. Changes in miRNA ...
Acute graft-versus-host disease (aGVHD) and cytomegalovirus reactivation are important complications after allogeneic stem cell transplantation (alloHSCT). Here, we evaluated the impact of treatment with alemtuzumab on the occurrence of aGVHD, cytomegalovirus reactivation and survival after alloHSCT. This was a prospective cohort study conducted at the allo-HSCT unit of Hospital das Clínicas, U...
Patients with steroid-resistant acute graft versus host disease (aGVHD) have a dismal prognosis, with mortality rates in excess of 90%. We sought to identify a subgroup of patients less likely to benefit from initial therapy with corticosteroids as well as the impact of response on day 14 on outcome. Retrospective evaluation was performed of patients with biopsy-proven aGVHD treated with cortic...
چکید ه سابقه و هدف GVHD بیماری است که در 40-20 درصد از گیرندگان پیوند هماهنگ از نظر HLA دیده میشود. شماری از پژوهشها نشان دادهاند که چند شکلی در ژنهای سایتوکاین، بر مشکلات پس از پیوند تاثیر میگذارد. یکی از اعضای این خانواده( IL-1RN ) آنتاگونیست گیرنده (IL-1Ra)IL-1 را کد میکند که یک مولکول با خاصیت ضد التهابی است و با IL-1 a و IL-1 b در اتصال به گیرنده رقابت میکند. میزان شرکت IL-1 د...
The optimal selection of recipient-donor pair and accurate prediction of acute graft-versus-host disease (aGVHD) severity are always the two most crucial works in allogeneic hematopoietic stem cell transplantation (allo-HSCT), which currently rests mostly with HLA compatibility, the most polymorphic loci in the human genome, in clinic. Thus, there is an urgent need for a rapid and reliable quan...
BACKGROUND: The reliability to noninvasively identify features of inflammatory dermatoses by reflectance confocal microscopy (RCM) remains unknown. Specific consensus terminology with representative images is necessary ensure consistent feature-level interpretation among RCM readers. METHODS: Through an iterative process refinement and discussion five international experts, we developed a gloss...
While cord blood transplantation (CBT) is an effective therapy for hematologic malignancies, acute graft-versus-host disease (aGVHD) is a leading cause of transplant-related mortality (TRM). We investigated if biomarkers could predict aGVHD and TRM after day 28 in CBT recipients. Day 28 samples from 113 CBT patients were analyzed. Suppressor of tumorigenicity 2 (ST2) was the only biomarker asso...
Acute graft-versus-host disease (aGvHD) is a serious systemic complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when alloreactive donor-derived T cells recognize host-recipient antigens as foreign. The early events leading to GvHD seem to occur very soon, presumably within hours from the graft infusion. Therefore, when the first signs of aGvHD clinically mani...
OBJECTIVE To present the survival and evaluate the demographic characteristics as risk factors for acute and chronic graft versus host disease (GvHD) in 100 recipients of HLA identical related allogeneic peripheral blood stem cell transplantation. METHODS Indications for transplant were non-malignant and malignant haematological disorders. Bu/Cy conditioning was given for haematological malig...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید